MedPath

University of Oxford

University of Oxford logo
🇬🇧United Kingdom
Ownership
Private
Established
1096-01-01
Employees
10K
Market Cap
-
Website
http://www.ox.ac.uk

Shigella Sonnei 53G Human Infection Study in Kenyan Adults

Phase 1
Recruiting
Conditions
Shigellosis
Interventions
Biological: Shigella sonnei 53G
First Posted Date
2023-07-25
Last Posted Date
2025-03-13
Lead Sponsor
University of Oxford
Target Recruit Count
70
Registration Number
NCT05959616
Locations
🇰🇪

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya

Use of Procalcitonin, a Blood Test to Guide Antibiotic Therapy for Sepsis in Adults

Phase 3
Completed
Conditions
Sepsis
Interventions
Procedure: Procalcitonin measurement
First Posted Date
2023-07-21
Last Posted Date
2024-11-26
Lead Sponsor
University of Oxford
Target Recruit Count
532
Registration Number
NCT05955612
Locations
🇧🇩

Chattogram Medical College Hospital (CMCH), Chittagong, Chattogram, Bangladesh

A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines

Phase 3
Not yet recruiting
Conditions
Uncomplicated Plasmodium Falciparum Malaria
Interventions
Drug: Artemether-Lumefantrine-Amodiaquine (ALAQ)
Drug: Artemether-Lumefantrine (AL)
Drug: Artesunate-Amodiaquine (ASAQ)
First Posted Date
2023-07-19
Last Posted Date
2023-07-24
Lead Sponsor
University of Oxford
Target Recruit Count
1440
Registration Number
NCT05951595

The Effect of Obesity and Weight Loss in Heart Failure With Reduced Ejection Fraction.

Not Applicable
Recruiting
Conditions
Heart Failure With Reduced Ejection Fraction
Overweight
Heart Failure
Obesity
Interventions
Other: Diet intervention
First Posted Date
2023-07-12
Last Posted Date
2025-02-25
Lead Sponsor
University of Oxford
Target Recruit Count
110
Registration Number
NCT05942287
Locations
🇯🇪

Jersey General Hospital, Jersey, Jersey

🇬🇧

Jenny Rayner, Oxford, United Kingdom

A Study to Assess the Availability of Oral Primaquine and Its Inert Metabolite, Carboxyprimaquine, in the Body

Phase 1
Withdrawn
Conditions
Healthy
Pharmacokinetic
Interventions
Drug: Regimen 1 (Oral primaquine)
Drug: Regimen 2 (IV primaquine phosphate)
Drug: Regimen 3 (IV carboxyprimaquine)
First Posted Date
2023-07-10
Last Posted Date
2024-05-06
Lead Sponsor
University of Oxford
Registration Number
NCT05938608
Locations
🇹🇭

Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

CommunICation of bEnefit Risk Information: an Online Randomised Controlled Trial

Not Applicable
Completed
Conditions
Confidence, Self
Knowledge, Attitudes, Practice
Literacy
Interventions
Device: Vitruvian plot
Device: Kilim plot
Device: Summary of findings table
First Posted Date
2023-06-26
Last Posted Date
2023-12-18
Lead Sponsor
University of Oxford
Target Recruit Count
2178
Registration Number
NCT05917639
Locations
🇬🇧

Oxford Precision Psychiatry Lab (OxPPL), Oxford, United Kingdom

Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention

Recruiting
Conditions
Pleural Neoplasms
Complications, Pulmonary
Pneumothorax
Pleural Effusion
Pleural Diseases
Pleural Mesothelioma
Pleural Infection
Pleural Metastases
Pleural Effusion, Malignant
Procedural Complication
Interventions
Procedure: Pleural interventions
First Posted Date
2023-06-18
Last Posted Date
2023-06-18
Lead Sponsor
University of Oxford
Target Recruit Count
2000
Registration Number
NCT05910112
Locations
🇬🇧

Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom

The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection Fraction

Not Applicable
Recruiting
Conditions
Obesity
Heart Failure With Preserved Ejection Fraction
Interventions
Other: Diet intervention
First Posted Date
2023-05-30
Last Posted Date
2024-04-24
Lead Sponsor
University of Oxford
Target Recruit Count
120
Registration Number
NCT05878912
Locations
🇬🇧

Oxford Centre for Clinical Magnetic Resonance Research, John Radcliffe Hospital, Oxford, United Kingdom

KLH Challenge to Explore the Human Immune Response

Not Applicable
Recruiting
Conditions
Immune Response
Interventions
Biological: Keyhole-Limpet Hemocyanin
Drug: Saline
First Posted Date
2023-05-25
Last Posted Date
2023-05-25
Lead Sponsor
University of Oxford
Target Recruit Count
39
Registration Number
NCT05876195
Locations
🇬🇧

NIHR Oxford Experimental Medicine Clinical Research Facility, Oxford, United Kingdom

Mechanisms of Neurodynamic Treatments

Not Applicable
Recruiting
Conditions
Diffusion MRI
Physiotherapy
Carpal Tunnel Syndrome
Neurodynamic Treatment
Mechanistic Trial
Nerve Mobilisation
Interventions
Other: Advice
Other: Neurodynamic exercises
Drug: Steroid injection (Depomedrone 40mg)
First Posted Date
2023-05-16
Last Posted Date
2024-01-05
Lead Sponsor
University of Oxford
Target Recruit Count
108
Registration Number
NCT05859412
Locations
🇬🇧

Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath